virus
without
replic
machineri
depend
host
cell
prolifer
virus
interact
host
cell
activ
enzym
cofactor
requir
replic
respons
host
cell
thu
reflect
pathogen
properti
treatment
viral
diseas
drug
primarili
target
special
viral
protein
current
antivir
drug
includ
nucleotid
neuraminidas
enzym
revers
transcriptas
proteas
chemokin
receptor
mani
drug
target
viral
protein
fraught
cytotox
tend
caus
drug
although
drug
target
cellular
factor
pathway
advantag
overcom
cellular
barrier
toxic
compromis
reason
need
discov
altern
antivir
compound
minim
side
immunosuppress
patient
undergo
organ
transplant
suscept
cytomegaloviru
cmv
infect
could
caus
interestingli
two
immunosuppress
drug
mycophenol
acid
better
anticmv
activ
allow
good
graft
immunosuppress
drug
develop
target
specif
protein
kinas
essenti
viru
replic
among
artesun
drug
inhibit
cellular
kinas
signal
sirolimu
everolimu
rapamycin
inhibitor
target
cellular
drug
shown
activ
ganciclovir
foscarnetresist
cmv
review
discuss
associ
cellular
pathway
mediat
cmv
cyclosporin
csa
demonstr
csa
use
immunosuppress
drug
organ
transplant
anticmv
agent
cmv
dna
viru
herpesvirida
highli
speciesspecif
human
cytomegaloviru
hcmv
studi
anim
result
develop
mani
anim
model
seropreval
studi
shown
popul
seroposit
immun
system
easili
control
viru
caus
activ
infect
facilit
lifelong
immunosuppress
transplant
recipi
hiv
patient
foetu
risk
acquir
cmv
high
risk
infect
solid
organ
transplant
sot
recipi
associ
serostatu
donor
recipi
type
transplant
organ
host
immun
statu
viral
factor
organ
tissu
transplant
cmv
infect
mostli
report
seroposit
cmvseroneg
recipi
rather
also
shown
hematopoiet
cell
transplant
greatest
risk
infect
donor
cmv
seroneg
recipi
seroposit
r
pregnant
women
among
factor
increas
risk
cmv
infect
socioeconom
statu
parasit
infect
cmv
viral
load
serostatu
age
noncaucasian
educ
level
close
contact
young
children
preval
cmv
infect
babi
born
mother
primari
cmv
infect
show
neurolog
diseas
birth
make
preval
cmvrelat
disabl
higher
childhood
risk
vertic
transmiss
cmv
higher
primari
nonprimari
cmv
infect
infect
symptomat
congenit
cmv
infect
may
also
primari
infect
occur
seroposit
women
seroneg
women
usa
congenit
infect
acquir
nonprimari
cmv
infect
primari
thu
congenit
infect
acquir
nonprimari
cmv
infect
compar
primari
infect
regard
cmv
diseas
outcom
evid
symptomat
outcom
primari
nonprimari
cmv
infect
greatest
risk
cmv
infect
period
fetal
organogenesi
first
earli
second
trimest
vertic
transmiss
mostli
occur
third
trimest
fetus
mostli
born
healthi
seem
differ
symptom
among
babi
born
pregnanc
affect
primari
nonprimari
cmv
mortal
symptomat
congenit
infect
result
liver
dysfunct
coagul
disord
secondari
bacteri
complic
cmv
congenit
infect
includ
central
nerv
system
cn
diseas
meningoenceph
calcif
microcephali
disrupt
neuron
migrat
germin
matrix
cyst
ventriculomegali
cellular
hyperplasia
lethargi
hypotonia
seizur
complic
sever
cmv
infect
occur
earli
stage
newborn
postnat
cmv
infect
caus
hepat
neutropenia
thrombocytopenia
prematur
low
birth
sensorineur
hear
loss
snhl
due
viru
replic
inner
ear
report
young
disord
develop
earli
birth
symptomat
asymptomat
neonat
later
childhood
children
approxim
infant
congenit
infect
may
manifest
sever
symptomat
cytomegal
inclus
diseas
cid
cytomegal
inclus
bodi
diseas
cibd
infant
cid
develop
cmv
neurolog
cmv
reach
brain
foetus
brain
cmv
infect
associ
viral
replic
endotheli
cell
barrier
bbb
process
facilit
viruscross
brain
parenchyma
access
anoth
way
viru
enter
brain
infect
ependym
cell
choroid
plexu
lead
dissemin
viru
cerebrospin
fluid
subsequ
infect
brain
viru
establish
latent
infect
myeloid
cell
eventu
infiltr
brain
develop
microglia
destruct
injuri
bbb
endotheli
cell
result
extravas
monocyt
facilit
brain
nervou
tissu
cmv
induc
injuri
interf
cell
differenti
morphogenesi
surviv
control
apoptosi
mechan
infect
neural
stem
cell
interf
brain
development
process
impact
cmv
replic
endovascular
viral
replic
interfer
brain
develop
migrat
neocort
neuron
cortic
plate
caus
cyclophilin
cyp
group
highli
conserv
cellular
found
ubiquit
anim
plant
tissu
protein
uniqu
chemic
structur
consist
amino
acid
amino
acid
contain
variat
interact
domain
among
protein
variou
locat
differ
least
cyp
although
differ
distribut
tissu
organ
local
structur
similar
peptidylprolyl
isomeras
ppias
human
seven
cyp
kda
identifi
hcypa
hcypb
hcypc
hcypd
hcype
cellular
function
cyp
observ
protein
fold
cyclophilin
cypa
bind
cyclosporin
csa
first
isol
bovin
cypa
resembl
high
abund
cyp
eukaryot
concentr
rang
total
cellular
cypa
encod
gene
chromosom
consist
amino
acid
molecular
weight
human
cypa
compos
eight
antiparallel
structur
enclos
two
locat
hydrophob
core
cypa
contain
one
hydrophob
seven
aromat
residu
within
drum
molecul
csabind
area
csabind
site
compos
loop
region
four
cypa
play
import
role
variou
cellular
function
includ
inflamm
protein
stimul
immun
respons
produc
inflammatori
cell
endotheli
cell
monocyt
vascular
smooth
muscl
cell
extracellular
cypa
interact
cell
membran
heparin
receptor
also
function
chemoattract
monocyt
neutrophil
eosinophil
like
cyp
cypa
act
chaperon
regul
cellular
receptor
express
protein
also
involv
sever
signal
pathway
signal
transduct
pathway
uniqu
lymphocyt
cellspecif
tyrosin
kinas
itk
brain
cypa
mostli
local
play
role
neuron
differenti
embryo
growth
adult
cortic
cypa
maintain
integr
function
bbb
protect
neuron
traumat
brain
injuri
block
bbb
permeabl
effect
ischemia
oxid
brain
injuri
cypa
induc
endotheli
cell
prolifer
migrat
well
recruit
monocyt
repair
brain
blood
moreov
cypa
induc
extracellular
signalregul
kinas
erk
protein
kinas
b
pkb
akt
signal
bind
cell
surfac
receptor
bind
stimul
express
antiapoptot
protein
mediat
neurogenesi
brain
protect
sever
csa
deriv
figur
interact
well
virus
caus
seriou
side
among
deriv
alisporivir
figur
nonimmunosuppress
analog
csa
synthes
contain
sarcosin
instead
dmethylalanin
posit
ppias
domain
methylleucin
instead
ethylvalin
posit
calcineurin
domain
modif
alter
ppias
activ
calcineurinbind
abil
howev
alisporivir
still
result
side
effect
includ
revers
hyperbilirubinemia
pancreat
use
combin
ribavirin
treat
hepat
c
viru
hcv
figur
b
anoth
nonimmunosuppress
analog
csa
similar
structur
parent
molecul
one
modif
methylleucin
posit
replac
methylisoleucin
deriv
antivir
exhibit
pharmacokinet
profil
csa
without
figur
c
csa
deriv
inhibit
hcv
without
detect
inhibit
calcineurin
phosphatas
treatment
drug
associ
transient
increas
interferon
cytokin
respons
clearanc
anoth
deriv
csa
metabol
stabl
favor
pharmacokinet
allow
less
frequent
low
therapeut
dose
drug
also
effect
bilirubin
transport
without
affect
major
protein
drug
sanglifehrin
sfa
figur
new
immunosuppress
isol
streptomyc
strain
protein
interact
strongli
calcineurin
also
potent
inhibitor
mitochondri
permeabl
transit
heart
reperfus
cmv
cellular
entri
replic
involv
sever
factor
includ
epiderm
growth
factor
receptor
egfr
integrin
plateletderiv
growth
factor
bind
receptor
initi
homeostasi
activ
phospholipas
c
releas
arachidon
acid
metabolit
diacylglycerol
activ
protein
kinas
c
inositol
triphosph
induc
calcium
viru
also
bind
integrin
anoth
receptor
mediat
actin
depolymer
facilit
viru
transloc
activ
src
pathway
alter
cytoskeleton
arrang
also
associ
activ
integrin
egfr
receptor
reduc
activ
rhoa
viru
activ
extracellular
signalregul
kinas
erk
also
known
mapk
pathway
interact
occur
kinas
import
viral
hcmv
replic
requir
activ
major
immedi
earli
promot
miep
respons
transcript
gene
cell
specif
promot
protein
activ
hcmv
either
independ
miep
special
site
cell
transcript
factor
either
stimul
repress
transcript
crebatf
ying
repressor
factor
erf
repress
transcript
occur
factor
includ
involv
posttransl
modif
hcmvpermiss
cell
miep
associ
acetyl
histon
peripher
blood
monocyt
miep
associ
heterochromatin
protein
chromosom
protein
implic
gene
hcmv
remain
latent
monocyt
serv
carrier
viru
although
mechan
reactiv
hcmv
still
known
suggest
host
complex
facilit
chromatin
transcript
fact
bind
miep
inhibit
complex
inhibit
viru
hcmv
alter
express
cell
cycl
regulatori
protein
cyclindepend
infect
cell
arrest
cell
cycl
macromolecul
need
cell
growth
viru
replic
synthes
hcmv
transactiv
promot
induc
accumul
howev
hcmv
repress
transactiv
outcom
interact
includ
stimul
dna
synthesi
cell
cycl
arrest
inhibit
viru
also
respond
alter
cell
growth
activ
host
gene
interact
histon
deacetylas
hdac
retinoblastoma
rb
tumor
suppressor
protein
via
lxcxedepend
bind
rb
protein
transcript
factor
partial
control
cell
growth
hcmvinfect
cell
pocket
protein
cell
growth
arrest
occur
rb
protein
repress
transcript
activ
transcript
bind
transcript
factor
caus
releas
activ
ecdk
allow
cell
cycl
progress
phase
hcmv
increas
express
tumor
suppressor
factor
infect
hcmv
bind
although
hcmv
block
hcmv
inhibit
apoptosi
pathway
sever
strategi
hcmv
stimul
antiapoptot
signal
pathway
delay
onset
also
cmv
gene
viral
inhibitor
apoptosi
vica
gene
encod
viral
mitochondrialoc
inhibitor
apoptosi
vmia
affect
permeabil
mitochondri
outer
membran
prevent
releas
cytochrom
c
necessari
activ
proapoptot
adapt
surviv
viru
host
cell
enhanc
major
tegument
protein
protein
protein
bind
cyclin
caus
cyclin
phosphoryl
avoid
cdkmediat
inhibit
viral
cmv
contain
gene
encod
cxc
chemokin
viru
use
cytokin
activ
preferenti
attract
neutrophil
serv
viru
viru
also
possess
ul
gene
induc
hcmv
genom
contain
gproteincoupl
receptor
gpcr
gpcr
prevent
leukocyt
recogn
hcmvinfect
cell
block
effect
leukocyt
neighbour
best
character
among
gpcr
stimul
migrat
hcmvinfect
cell
vascular
injuri
site
lead
atherosclerosi
host
cell
infect
hcmv
express
type
interferon
ifn
ifnstimul
gene
proinflammatori
compon
innat
cellular
respons
requir
transcript
activ
interferon
regulatori
factor
defenc
mechan
hcmv
inhibit
product
ifn
block
respons
disrupt
signal
transduct
pathway
decreas
express
multipl
ifnrespons
hcmv
particularli
late
infect
stage
also
inhibit
signal
respons
product
proinflammatori
cytokin
csa
immunosuppress
potenti
cmv
immunosuppress
activ
csa
via
interact
cellular
pathway
mediat
cypa
sensit
cellular
pathway
fulli
control
cmv
viral
infect
addit
share
signal
mapk
jnk
involv
cypa
activ
replic
demonstr
mous
model
silenc
cypa
mrna
fact
cypa
requir
hcmv
lytic
infect
latenc
establish
also
regul
ie
protein
lytic
gene
express
hcmv
replic
cycl
util
cypa
may
deplet
concentr
organ
compromis
cellular
protein
fold
differenti
nervou
tissu
affect
infect
may
caus
cnsassoci
abnorm
phenomena
suggest
cypa
could
potenti
therapeut
target
treatment
hcmv
infect
although
csa
common
immunosuppress
drug
use
organ
transplant
mediat
hcmv
reactiv
vivo
complex
respons
may
result
overal
cmv
enter
cell
stimul
secret
type
ifn
well
proinflammatori
cytokin
critic
cmv
respons
control
cmv
immun
respons
cmv
carri
tolllik
stimul
evid
previou
studi
oper
legend
upregul
cmv
infect
involv
inflamm
similar
interact
establish
cmv
ectodomain
cmv
enter
cell
stimul
cypa
product
interact
mediat
viru
replic
earli
immun
respons
gene
signal
block
cmv
addit
activ
pathway
import
monocyt
macrophag
modul
cellular
microenviron
necessari
approv
cmv
cmv
success
downregul
encod
encod
us
microrna
necessari
cellular
modul
downregul
special
code
area
utr
sequenc
lead
reduc
activ
ifnrel
gene
induc
inhibit
immun
respons
mediat
inhibit
also
mediat
csa
block
cypa
function
subsequ
interact
mani
virus
success
replic
induc
oxid
cypa
import
mediat
xiao
et
al
demonstr
cmv
infect
induc
substanti
level
oxid
oxid
stress
stimul
cypa
product
cypa
play
role
activ
pathway
pathway
necessari
activ
transcript
factor
creb
chop
mediat
viral
cellular
gene
express
enhanc
viru
silenc
cypa
inhibit
viru
gene
csa
affect
express
cypa
activ
cypa
csa
cypa
target
drug
inhibit
cypamedi
pathway
addit
antioxid
compound
also
control
limit
viru
abil
cypa
mediat
inflammatori
respons
report
van
de
berg
et
cmv
also
mediat
inflammatori
respons
cmv
stimul
cypa
mediat
activ
pathway
mediat
viral
express
hcmv
promot
activ
mapkerk
addit
protein
cmv
mediat
viral
gene
well
stimul
cellular
express
factor
cjun
junb
creb
histon
acetyltransferas
crebbind
protein
cbp
associ
factor
pcaf
also
play
role
control
gene
activ
factor
mediat
viral
replic
respons
csa
antivir
drug
resembl
abund
ie
protein
mediat
viru
gene
express
reproduct
abil
overcom
csa
inhibit
cypa
stimul
viral
gene
express
addit
chemokinelik
receptor
protein
interact
hlac
hlag
affect
express
mhc
class
antigen
figur
enabl
virus
evad
immun
cmv
gene
express
occur
sequenc
express
earli
e
gene
occur
first
follow
ie
gene
express
eventu
declin
allow
inhibit
cypa
csa
format
complex
complex
inhibit
thu
viru
sinc
earli
e
gene
express
also
cascad
late
l
gene
encod
structur
protein
express
lead
blockag
viru
replic
product
viru
progeni
therefor
csa
may
activ
cmv
function
antivir
drug
inhibit
viru
replic
cypa
vital
hcmv
lytic
infect
latenc
establish
reactiv
protein
serv
target
treatment
hcmv
infect
current
review
describ
anticmv
activ
csa
immunosuppress
drug
commonli
use
organ
transplant
howev
drug
associ
hcmv
reactiv
toxic
immunosuppress
activ
drug
achiev
format
complex
suppress
organ
reject
inhibit
calciumcalmodulindepend
protein
major
ie
protein
encod
cmv
ie
gene
mediat
cmv
lytic
express
depend
protein
cellular
signal
interact
cascad
event
core
determin
whether
csa
activ
suppress
viru
prolifer
sinc
viral
infect
induc
express
inflammatori
thrive
immunosuppress
inhibitori
effect
csa
effect
earli
stage
viral
replic
cycl
immun
inflammatori
respons
still
limit
review
previous
publish
data
show
csa
anticmv
use
csa
combin
drug
approv
treatment
cmv
infect
may
also
prevent
develop
unwant
toxic
drug
resist
